NCT00736502已完成不适用
Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 280
- 试验地点
- 17
- 主要终点
- Proportion of Patients Reporting Adverse Events
研究概览
简要总结
The aim of this trial is to evaluate the safety and virological and immunological efficacy of Viramune® on a background of different antiretroviral drug combinations.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Proportion of Patients Reporting Adverse Events
时间窗: 48 weeks
the incidence of non serious adverse events and serious adverse events according to body system (= System Organ Class) and preferred term.
次要结局
- Virologic Response (VR)(48 weeks)
- Change in CD4+ Cell Count From Baseline to Week 48(Baseline and week 48)
研究者
研究点 (17)
Loading locations...
相似试验
已完成
2 期
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/RitonavirCOVID-19NCT05567952Pfizer436
已完成
不适用
Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19Omicron Variant of COVID-19NCT05813600Xiangao Jiang58
已完成
3 期
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionInfection, Human Immunodeficiency Virus IHIV InfectionNCT00440947ViiV Healthcare515
招募中
不适用
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in ChinaIntracranial ArteriosclerosisStenosis ArteryDrug-Eluting StentsIntracranial Artery StenosisNCT05692882Sino Medical Sciences Technology Inc.1,000
招募中
1 期
The Safety and Effectiveness of NV-A01 in Glioma PatientsAdvanced Glioblastoma PatientsNCT06193538First Affiliated Hospital of Wannan Medical College15